Point of care testing devices are gaining widespread approval for prompt medical diagnoses, especially in cardiology and INR testing. 



The Cardioband System (Valtech) has recently been introduced as a potential option for transcatheter repair of the mitral valve among patients with functional mitral regurgitation (FMR). It has a CE mark in Europe, and a study to evaluate its safety and efficacy is planned in the United States.[1]  Use of the Cardioband is intended to reduce the size of the annulus by placing an annuloplasty ring around it. 


As wearable and implantable patient monitoring or therapy devices become more sophisticated with advanced wireless connectivity to extract patient information and change the device functionality, there are growing concerns these technologies will be targets of hackers. The U.S. Food and Drug Administration (FDA) believes this poses a threat to patient safety.

December 29, 2016 — The American College of Cardiology (ACC), along with several partnering organizations, recently released updated appropriate use criteria for performing coronary revascularization in patients with acute coronary syndromes.

Patients with acute coronary syndromes suffer from sudden, reduced blood flow to the heart, requiring quick diagnosis and care. Coronary revascularization is the restoration of this blood flow to the heart commonly by coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI).

CSI, Imaging and Innovation 2017

Heart Beat of Cardiology: Practical Application of Echocardiography

Echo on Marco Island: Case-Based Approach

Subscribe Now